A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112

Completed · Phase 1/Phase 2

Conditions studied: X-Linked Retinitis Pigmentosa

In brief

The objective of the study is to evaluate the safety, tolerability and efficacy of a single sub-retinal injection of BIIB112 in participants with X-linked retinitis pigmentosa (XLRP).

Key facts

Study ID

NCT03116113

Run by

Biogen

People needed

50

Starts

2017-03-08

Expected to finish

2020-11-18

Last updated by the study team

2024-01-18

Who can join

Age: 10 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Research Site — Gainesville, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Portland, Oregon, United States
• Research Site — Philadelphia, Pennsylvania, United States
• Research Site — Dallas, Texas, United States
• Research Site — Manchester, United Kingdom
• Research Site — Oxford, United Kingdom
• Research Site — Southampton, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.